Dominik R. Bach, native from Germany’s Rhineland region, studied psychology in Bielefeld and Berlin, and then medicine in Berlin. He obtained a PhD in neuropsychology and worked 2007-2010 as post doc at the Wellcome Centre for Human Neuroimaging, University College London. He trained in clinical psychiatry, neurology and internal medicine in Bern and Berlin, and is a registered specialist for psychiatry and psychotherapy. In 2013, he became assistant professor at University of Zurich. In 2019, he was appointed principal research fellow at the Queen Square UCL Institute of Neurology, University College London, where he became Professor of Cognitive-Computational and Clinical Neuroscience in 2021. In 2022, he was took up the Hertz Chair for Artificial Intelligence and Neuroscience at University of Bonn. Dominik Bach is interested in using AI-inspired computational models to understand brain function at its limits. His primary focus is on the cognitive mechanisms of threat avoidance and threat prediction in humans.

Dominik R. Bach, native from Germany’s Rhineland region, studied psychology in Bielefeld and Berlin, and then medicine in Berlin. He obtained a PhD in neuropsychology and worked 2007-2010 as post doc at the Wellcome Centre for Human Neuroimaging, University College London. He trained in clinical psychiatry, neurology and internal medicine in Bern and Berlin, and is a registered specialist for psychiatry and psychotherapy. In 2013, he became assistant professor at University of Zurich. In 2019, he was appointed principal research fellow at the Queen Square UCL Institute of Neurology, University College London, where he became Professor of Cognitive-Computational and Clinical Neuroscience in 2021. In 2022, he was took up the Hertz Chair for Artificial Intelligence and Neuroscience at University of Bonn. Dominik Bach is interested in using AI-inspired computational models to understand brain function at its limits. His primary focus is on the cognitive mechanisms of threat avoidance and threat prediction in humans.

Matthew L. Baum, M.D., Ph.D., D.Phil. is a resident physician in psychiatry at Brigham and Women’s Hospital, Boston, and a clinical fellow at Harvard Medical School. He holds a B.S. and M.S. in Molecular, Cellular, and Developmental Biology from Yale University; an M.Sc. in Neuroscience from Trinity College, Dublin (funded by a George Mitchell Scholarship); a D.Phil. in Neuroethics from Oxford University (funded by a Rhodes Scholarship); and an M.D. and Ph.D. (in Neuroscience) from Harvard Medical School. He is the author of the book, “The Neuroethics of Biomarkers: What the Development of Bioprediction Means for Moral Responsibility, Justice, and the Nature of Mental Disorder” (Oxford University Press), which was awarded the Carol Davis Ethics prize by the American Psychiatric Association for an “outstanding contribution to literature on the ethics of psychiatry”. He is a past plenary speaker at the annual meeting of the International Neuroethics Society, and has taught medical ethics at Oxford and Harvard. His neuroscientific work has focused on the complement cascade, and its regulation, in a synaptic pruning hypothesis of schizophrenia and he currently aims to integrate scientific, neuroethical, and clinical pursuit of immune-molecule dysfunction in psychiatry.

Matthew L. Baum, M.D., Ph.D., D.Phil. is a resident physician in psychiatry at Brigham and Women’s Hospital, Boston, and a clinical fellow at Harvard Medical School. He holds a B.S. and M.S. in Molecular, Cellular, and Developmental Biology from Yale University; an M.Sc. in Neuroscience from Trinity College, Dublin (funded by a George Mitchell Scholarship); a D.Phil. in Neuroethics from Oxford University (funded by a Rhodes Scholarship); and an M.D. and Ph.D. (in Neuroscience) from Harvard Medical School. He is the author of the book, “The Neuroethics of Biomarkers: What the Development of Bioprediction Means for Moral Responsibility, Justice, and the Nature of Mental Disorder” (Oxford University Press), which was awarded the Carol Davis Ethics prize by the American Psychiatric Association for an “outstanding contribution to literature on the ethics of psychiatry”. He is a past plenary speaker at the annual meeting of the International Neuroethics Society, and has taught medical ethics at Oxford and Harvard. His neuroscientific work has focused on the complement cascade, and its regulation, in a synaptic pruning hypothesis of schizophrenia and he currently aims to integrate scientific, neuroethical, and clinical pursuit of immune-molecule dysfunction in psychiatry.

Dr. Bazinet received his BSc from the University of Western Ontario and completed his PhD under the supervision of Dr. Stephen Cunnane at the University of Toronto in 2003.  Dr. Bazinet then completed a postdoctoral fellowship in Dr. Stanley Rapoport’s Brain Physiology and Metabolism Section at the National Institute on Aging, National Institutes of Health. Dr. Bazinet joined the University of Toronto in 2006, where he is currently a Professor, Associate Chair of Research and Innovation and Canada Research Chair in Brain Lipid Metabolism. Dr. Bazinet is the recipient of several awards, including the Early Career Award from the International Society for the Study of Fatty Acids and Lipids; the Jordi-Folch-Pi Memorial Award from the American Society for Neurochemistry; the Future Leaders Award from the International Life Sciences Institute, the Young Scientist Award for the American Oil Chemists’ Society, the Early Researcher Award from the Canadian Society for Nutrition and a the Ralph Holman life time achievement award from the Oil Chemists’ Society. Dr. Bazinet sits on several editorial boards and is currently Editor-in-Chief of Prostaglandins, Leukotrienes and Essential Fatty Acids as well as a Senior Associate Editor of Lipids. The overall goal of Dr. Bazinet’s research program is to identify the mechanisms that regulate brain lipid metabolism (signaling) and to identify the role of brain lipid metabolism in the pathogenesis of neurodegenerative diseases and neuropsychiatric disorders. Dr. Bazinet has published over 200 papers, largely in the field of brain fatty acid metabolism and is co-author of the joint WHO/FAO joint expert consultation on dietary fats and the central nervous system during aging and disease. Dr. Bazinet is currently the past-president of the International Society for the Study of Fatty Acids and Lipids (ISSFAL).

Dr. Bazinet received his BSc from the University of Western Ontario and completed his PhD under the supervision of Dr. Stephen Cunnane at the University of Toronto in 2003.  Dr. Bazinet then completed a postdoctoral fellowship in Dr. Stanley Rapoport’s Brain Physiology and Metabolism Section at the National Institute on Aging, National Institutes of Health. Dr. Bazinet joined the University of Toronto in 2006, where he is currently a Professor, Associate Chair of Research and Innovation and Canada Research Chair in Brain Lipid Metabolism. Dr. Bazinet is the recipient of several awards, including the Early Career Award from the International Society for the Study of Fatty Acids and Lipids; the Jordi-Folch-Pi Memorial Award from the American Society for Neurochemistry; the Future Leaders Award from the International Life Sciences Institute, the Young Scientist Award for the American Oil Chemists’ Society, the Early Researcher Award from the Canadian Society for Nutrition and a the Ralph Holman life time achievement award from the Oil Chemists’ Society. Dr. Bazinet sits on several editorial boards and is currently Editor-in-Chief of Prostaglandins, Leukotrienes and Essential Fatty Acids as well as a Senior Associate Editor of Lipids. The overall goal of Dr. Bazinet’s research program is to identify the mechanisms that regulate brain lipid metabolism (signaling) and to identify the role of brain lipid metabolism in the pathogenesis of neurodegenerative diseases and neuropsychiatric disorders. Dr. Bazinet has published over 200 papers, largely in the field of brain fatty acid metabolism and is co-author of the joint WHO/FAO joint expert consultation on dietary fats and the central nervous system during aging and disease. Dr. Bazinet is currently the past-president of the International Society for the Study of Fatty Acids and Lipids (ISSFAL).

Silvia Cappello is a research group leader at the Max Planck Institute of Psychiatry. The major focus of her laboratory is to understand the basic molecular and cellular mechanisms regulating the development of the human brain. Silvia Cappello studied biotechnology at the University of Bologna, Italy, and carried out her PhD in the University of Padua, Italy and in the laboratory of Magdalena Götz, at the Helmholtz Center. As a postdoctoral fellow, she studied mechanisms regulating neurogenesis and neuronal migration with Magdalena Götz and in the laboratory of Richard Vallee at Columbia University.

Silvia Cappello is a research group leader at the Max Planck Institute of Psychiatry. The major focus of her laboratory is to understand the basic molecular and cellular mechanisms regulating the development of the human brain. Silvia Cappello studied biotechnology at the University of Bologna, Italy, and carried out her PhD in the University of Padua, Italy and in the laboratory of Magdalena Götz, at the Helmholtz Center. As a postdoctoral fellow, she studied mechanisms regulating neurogenesis and neuronal migration with Magdalena Götz and in the laboratory of Richard Vallee at Columbia University.

I studied Biology and obtained my PhD in Neuroscience in 2009 from the Ruhr-University Bochum (Germany). Afterwards, I received an EMBO long-term fellowship to do my postdoctoral research at the University of Edinburgh (UK) in the groups of Charles ffrench-Constant and David Lyons. In 2015, I became a Principal Investigator at the Technical University of Munich (Germany), funded by an Emmy Noether Fellowship and an ERC Starting Grant. In 2020, I moved back to University of Edinburgh where I am a Wellcome Trust Senior Research Fellow.
Throughout my career, I have been interested in the biology of oligodendrocyte precursor cells, which comprise about 5% of all brain cells lifelong. We aim to understand how these cells communicate with surrounding neurons, and how these interactions affect form and function of the central nervous system. In our research, we use zebrafish as model organism and a wide range of complementary methods, including high-resolution optical microscopy of live cell reporters, optophysiology and biomolecular sensor imaging, cellular and genetic manipulations, as well as behavioural analysis.

I studied Biology and obtained my PhD in Neuroscience in 2009 from the Ruhr-University Bochum (Germany). Afterwards, I received an EMBO long-term fellowship to do my postdoctoral research at the University of Edinburgh (UK) in the groups of Charles ffrench-Constant and David Lyons. In 2015, I became a Principal Investigator at the Technical University of Munich (Germany), funded by an Emmy Noether Fellowship and an ERC Starting Grant. In 2020, I moved back to University of Edinburgh where I am a Wellcome Trust Senior Research Fellow.
Throughout my career, I have been interested in the biology of oligodendrocyte precursor cells, which comprise about 5% of all brain cells lifelong. We aim to understand how these cells communicate with surrounding neurons, and how these interactions affect form and function of the central nervous system. In our research, we use zebrafish as model organism and a wide range of complementary methods, including high-resolution optical microscopy of live cell reporters, optophysiology and biomolecular sensor imaging, cellular and genetic manipulations, as well as behavioural analysis.

Birgit Derntl (née Hoheisel) is a psychologist and trained psychotherapist. She studied psychology in Vienna and completed her PhD on amygdala activation and facial emotion processing in 2006. As post-doctoral fellow at RWTH Aachen University and University of Vienna she performed (neuroimaging) studies on diverse emotional capacities in healthy females and males as well as patients with mental disorders, besides her clinical training. In 2011 she joined RWTH Aachen University as assistant professor and received her full professorship on innovative neuroimaging at the Department of Psychiatry and Psychotherapy, University of Tübingen, in 2015. Her research interests are in the field of social and affective psychoneuroendocrinology with a strong focus on how sex and gender as well as (female) hormonal transition periods affect brain architecture, behavior and mental health. The topics investigated in her group are stress, empathy, emotion processing and emotion regulation, sexuality and approach/avoidance behavior using visual, auditory and olfactory (body odors) stimuli often relying on multi-modal assessement.

Birgit Derntl (née Hoheisel) is a psychologist and trained psychotherapist. She studied psychology in Vienna and completed her PhD on amygdala activation and facial emotion processing in 2006. As post-doctoral fellow at RWTH Aachen University and University of Vienna she performed (neuroimaging) studies on diverse emotional capacities in healthy females and males as well as patients with mental disorders, besides her clinical training. In 2011 she joined RWTH Aachen University as assistant professor and received her full professorship on innovative neuroimaging at the Department of Psychiatry and Psychotherapy, University of Tübingen, in 2015. Her research interests are in the field of social and affective psychoneuroendocrinology with a strong focus on how sex and gender as well as (female) hormonal transition periods affect brain architecture, behavior and mental health. The topics investigated in her group are stress, empathy, emotion processing and emotion regulation, sexuality and approach/avoidance behavior using visual, auditory and olfactory (body odors) stimuli often relying on multi-modal assessement.

Aline Desmedt is Full Professor of Neuroscience in Bordeaux University in France and team leader in the Neurocentre Magendie (INSERM U1215). Her research is dedicated to the neurobiological bases of declarative memory, with a particular focus on the multilevel brain alterations underlying post-traumatic stress disorder (PTSD)-related memory. In particular, having developed the first animal model recapitulating the two memory components of traumatic memory (i.e. emotional hypermnesia & contextual amnesia, Kaouane et al., Science, 2012), she demonstrated that altered hippocampal function can cause this pathological memory in mice and that re-contextualization of traumatic memory, which is a hippocampus-dependent process, normalizes, and thus heals, this pathological memory (e.g. Al Abed et al., Nature Com, 2020 ; Ducourneau et al., Mol Psy, 2020 ; Bouarab et al., Mol Psy, 2021). She earned her PhD in Neuroscience from the Bordeaux University, and completed postdoctoral training at the Weizmann Institute of Science in Israel. She is general secretary (France) and co-founder of the “France-Israel Neuroscience Neurology and Psychiatry Society” (FINNePS) and member of an international research network (IRN: France-Israel). She coordinated several international and national scientific projects dedicated to the neural bases of traumatic memory and carried out several industrial contracts focused on prevention and treatment of PTSD-like memory.

Aline Desmedt is Full Professor of Neuroscience in Bordeaux University in France and team leader in the Neurocentre Magendie (INSERM U1215). Her research is dedicated to the neurobiological bases of declarative memory, with a particular focus on the multilevel brain alterations underlying post-traumatic stress disorder (PTSD)-related memory. In particular, having developed the first animal model recapitulating the two memory components of traumatic memory (i.e. emotional hypermnesia & contextual amnesia, Kaouane et al., Science, 2012), she demonstrated that altered hippocampal function can cause this pathological memory in mice and that re-contextualization of traumatic memory, which is a hippocampus-dependent process, normalizes, and thus heals, this pathological memory (e.g. Al Abed et al., Nature Com, 2020 ; Ducourneau et al., Mol Psy, 2020 ; Bouarab et al., Mol Psy, 2021). She earned her PhD in Neuroscience from the Bordeaux University, and completed postdoctoral training at the Weizmann Institute of Science in Israel. She is general secretary (France) and co-founder of the “France-Israel Neuroscience Neurology and Psychiatry Society” (FINNePS) and member of an international research network (IRN: France-Israel). She coordinated several international and national scientific projects dedicated to the neural bases of traumatic memory and carried out several industrial contracts focused on prevention and treatment of PTSD-like memory.

Amanda M. Dettmer, PhD, is an Associate Research Scientist at the Yale Child Study Center, where she leads the Human and Animal Integrated Research (HAIR) Lab. She is a comparative psychologist and behavioral neuroscientist with over 20 years of experience studying nonhuman primate models of child health and development. Her research program examines the impact of early life factors and individual differences on health across the lifespan in nonhuman primate models of human development and health. Dr. Dettmer studies early life factors – both prenatal and postnatal – that shape individual differences in cognitive, social, and behavioral development in the context of risk or resilience to chronic stress. For this research, she employs multidisciplinary approaches including ethology, neuroendocrinology, immunology, and epigenetics. By studying nonhuman primates across the lifespan, Dr. Dettmer aims to understand the longitudinal and intergenerational effects of early life experiences – both how early life adversity and naturally-occurring variations in parental care influence children’s development. Dr. Dettmer also works with human populations, and she is launching studies examining children’s stress regulation as a function of educational setting and following after-school enrichment programs. Dr. Dettmer was the 2017-18 American Psychological Association (APA) Executive Branch Science Fellow and is President-Elect of APA Division 6 (Society for Behavioral Neuroscience and Comparative Psychology).

Amanda M. Dettmer, PhD, is an Associate Research Scientist at the Yale Child Study Center, where she leads the Human and Animal Integrated Research (HAIR) Lab. She is a comparative psychologist and behavioral neuroscientist with over 20 years of experience studying nonhuman primate models of child health and development. Her research program examines the impact of early life factors and individual differences on health across the lifespan in nonhuman primate models of human development and health. Dr. Dettmer studies early life factors – both prenatal and postnatal – that shape individual differences in cognitive, social, and behavioral development in the context of risk or resilience to chronic stress. For this research, she employs multidisciplinary approaches including ethology, neuroendocrinology, immunology, and epigenetics. By studying nonhuman primates across the lifespan, Dr. Dettmer aims to understand the longitudinal and intergenerational effects of early life experiences – both how early life adversity and naturally-occurring variations in parental care influence children’s development. Dr. Dettmer also works with human populations, and she is launching studies examining children’s stress regulation as a function of educational setting and following after-school enrichment programs. Dr. Dettmer was the 2017-18 American Psychological Association (APA) Executive Branch Science Fellow and is President-Elect of APA Division 6 (Society for Behavioral Neuroscience and Comparative Psychology).

Dr. Martijn Figee is associate professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. His clinical expertise and research focus on deep brain stimulation (DBS) of basal ganglia circuits in neuropsychiatric disorders such as obsessive-compulsive disorder (OCD), depression and Parkinson’s disease, and how these circuits can be selectively modulated for personalized treatment.

Dr. Martijn Figee is associate professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. His clinical expertise and research focus on deep brain stimulation (DBS) of basal ganglia circuits in neuropsychiatric disorders such as obsessive-compulsive disorder (OCD), depression and Parkinson’s disease, and how these circuits can be selectively modulated for personalized treatment.

I am a research fellow at INSERM and am based at the brain imaging centrer « cyceron », in Caen, France. My work is articulated around 2 lines of research: the cognitive and clinical neuroscience of motivated forgetting, and the role of collective memory in shaping individual memories. My primary focus is centered around the concept of memory suppression and to develop a comprehensive neurobiological model of this phenomenon using neuroimaging and electroencephalography, and a better description of its role on mental health and emotional states. In this context, I am leading a multiwave longitudinal neuroimaging study in a cohort of direct survivors of the 11/13 Paris terrorist attacks, aiming to understand the role of memory suppression to combat post-traumatic stress-related disorders. This research is articulated around the “November 13” research program, a large transdisciplinary program which studies the evolution of memory narratives of the attacks over a period of 10 years through filmed interviews of 1000 individuals. In the future, I hope to combine these research frameworks to apprehend the concept of resilience to trauma and forgetting through an integrated and broader perspective combining collective and brain dynamics.

I am a research fellow at INSERM and am based at the brain imaging centrer « cyceron », in Caen, France. My work is articulated around 2 lines of research: the cognitive and clinical neuroscience of motivated forgetting, and the role of collective memory in shaping individual memories. My primary focus is centered around the concept of memory suppression and to develop a comprehensive neurobiological model of this phenomenon using neuroimaging and electroencephalography, and a better description of its role on mental health and emotional states. In this context, I am leading a multiwave longitudinal neuroimaging study in a cohort of direct survivors of the 11/13 Paris terrorist attacks, aiming to understand the role of memory suppression to combat post-traumatic stress-related disorders. This research is articulated around the “November 13” research program, a large transdisciplinary program which studies the evolution of memory narratives of the attacks over a period of 10 years through filmed interviews of 1000 individuals. In the future, I hope to combine these research frameworks to apprehend the concept of resilience to trauma and forgetting through an integrated and broader perspective combining collective and brain dynamics.

Valeria Gazzola studied Biology in Parma – Italy – and started her scientific career in Rizzolatti's lab, where mirror neuron where first recorded. She then moved to the Netherlands where her PhD and postdoctoral research established that somatosensory cortices, normally involved in processing the sensations on our body, play a critical role in social cognition, extending her work from action-related mirror responses to the domain of sensation and emotions. In 2010 she moved to Amsterdam, where she leads the Mechanisms of Social Behavior group at the Netherlands Institute for Neuroscience of the KNAW and is an associate professor at the University of Amsterdam. Her research is financed by prestigious National and European grants, and investigates the causal relationship between mirror like activity and pro- and anti- social behavior by using a combination of fMRI (functional magnetic resonance imaging), EEG (electrical encephalography), tDCS (transcranial direct current stimulation) and TMS (transcranial magnetic stimulation). Her work, published in renown journals, places her at the forefront of an effort to critically assess the relationship between brain regions associated with empathy and actual social behavior. Her international standing is apparent from her recent election to the Young Academy of Europe, through which she hopes to contribute to the recognition of diversity in academia.

Valeria Gazzola studied Biology in Parma – Italy – and started her scientific career in Rizzolatti's lab, where mirror neuron where first recorded. She then moved to the Netherlands where her PhD and postdoctoral research established that somatosensory cortices, normally involved in processing the sensations on our body, play a critical role in social cognition, extending her work from action-related mirror responses to the domain of sensation and emotions. In 2010 she moved to Amsterdam, where she leads the Mechanisms of Social Behavior group at the Netherlands Institute for Neuroscience of the KNAW and is an associate professor at the University of Amsterdam. Her research is financed by prestigious National and European grants, and investigates the causal relationship between mirror like activity and pro- and anti- social behavior by using a combination of fMRI (functional magnetic resonance imaging), EEG (electrical encephalography), tDCS (transcranial direct current stimulation) and TMS (transcranial magnetic stimulation). Her work, published in renown journals, places her at the forefront of an effort to critically assess the relationship between brain regions associated with empathy and actual social behavior. Her international standing is apparent from her recent election to the Young Academy of Europe, through which she hopes to contribute to the recognition of diversity in academia.

Michael Häusser earned his PhD from Oxford University under the supervision of Julian Jack. He subsequently worked with Nobel Laureate Bert Sakmann at the Max-Planck-Institute for Medical Research in Heidelberg and with Philippe Ascher at the Ecole Normale Superieure in Paris. He established his own laboratory at UCL in 1997 and became Professor of Neuroscience in 2001, where he has been a Principal Research Fellow of the Wellcome Trust since 2011. He is also currently the Facilitator of the International Brain Laboratory, a new global collaboration which aims to understand how the brain makes decisions.
Häusser’s work focuses on trying to understand the cellular and circuit basis of neural computations in the mammalian brain. To attack this problem his group is working at the interface between cellular and systems neuroscience using a combination of experiments and theory. The aim is to understand the cellular toolkit that enables single neurons to perform specific computations, and in turn how single neurons and their patterns of connections contribute to the computations performed by neural circuits during behaviour. His group has a special focus on neuronal dendrites, which actively transform synaptic inputs into specific neuronal output patterns. The experimental tools being used by the group include two-photon microscopy, patch-clamp recordings from dendrites, recordings using Neuropixels probes, and most recently the development of 'all-optical' approaches for simultaneous readout and manipulation of neuronal activity by combining two-photon imaging and two-photon optogenetics. These experiments are complemented by computational models of single neurons and networks of neurons.
Website: www.dendrites.org

Michael Häusser earned his PhD from Oxford University under the supervision of Julian Jack. He subsequently worked with Nobel Laureate Bert Sakmann at the Max-Planck-Institute for Medical Research in Heidelberg and with Philippe Ascher at the Ecole Normale Superieure in Paris. He established his own laboratory at UCL in 1997 and became Professor of Neuroscience in 2001, where he has been a Principal Research Fellow of the Wellcome Trust since 2011. He is also currently the Facilitator of the International Brain Laboratory, a new global collaboration which aims to understand how the brain makes decisions.
Häusser’s work focuses on trying to understand the cellular and circuit basis of neural computations in the mammalian brain. To attack this problem his group is working at the interface between cellular and systems neuroscience using a combination of experiments and theory. The aim is to understand the cellular toolkit that enables single neurons to perform specific computations, and in turn how single neurons and their patterns of connections contribute to the computations performed by neural circuits during behaviour. His group has a special focus on neuronal dendrites, which actively transform synaptic inputs into specific neuronal output patterns. The experimental tools being used by the group include two-photon microscopy, patch-clamp recordings from dendrites, recordings using Neuropixels probes, and most recently the development of 'all-optical' approaches for simultaneous readout and manipulation of neuronal activity by combining two-photon imaging and two-photon optogenetics. These experiments are complemented by computational models of single neurons and networks of neurons.
Website: www.dendrites.org

Dr. Timothy Hohman is an Associate Professor of Neurology, cognitive neuroscientist, and computational geneticist. Dr. Hohman's research leverages advanced computational approaches from genomics, proteomics, and neuroscience to identify novel markers of Alzheimer's disease risk and resilience. Within the Vanderbilt Memory and Alzheimer's Center, Dr. Hohman is the director of the Biomarker Core and Principal Investigator of the Computational Neurogenomics Team. He also directs the Genomics Core for the Preclinical Alzheimer's Disease Consortium and co-leads the Alzheimer's Disease Sequencing Project (ADSP) Phenotype Harmonization Consortium. 

Dr. Timothy Hohman is an Associate Professor of Neurology, cognitive neuroscientist, and computational geneticist. Dr. Hohman's research leverages advanced computational approaches from genomics, proteomics, and neuroscience to identify novel markers of Alzheimer's disease risk and resilience. Within the Vanderbilt Memory and Alzheimer's Center, Dr. Hohman is the director of the Biomarker Core and Principal Investigator of the Computational Neurogenomics Team. He also directs the Genomics Core for the Preclinical Alzheimer's Disease Consortium and co-leads the Alzheimer's Disease Sequencing Project (ADSP) Phenotype Harmonization Consortium. 

Ethan G. Hughes is an Assistant Professor in the Cell and Developmental Biology Department at the University of Colorado School of Medicine. He leads a laboratory focused on understanding how neuron-glial interactions modulate brain function and contribute to pathology in neurodegenerative disease. Dr. Hughes obtained his B.S. degree in Biology with Special Honors from George Washington University (2003) and his Ph.D. in the laboratory of Rita Balice-Gordon at the University of Pennsylvania (2009) studying the mechanisms of synapse formation and maintenance. As a postdoctoral fellow under the mentorship of Dwight Bergles at Johns Hopkins University, Dr. Hughes examined cellular dynamics of oligodendrocyte lineage cells and myelination in the adult brain using longitudinal in vivo two-photon microscopy. In 2016, Dr. Hughes joined the faculty at the University of Colorado School of Medicine. He is an awardee of the Whitehall Foundation Fellowship, Marilyn Hilton Award for Innovation in MS Research, Webb-Waring Biomedical Research Award, and a ACTRIMS Young Investigator Award. He serves on study sections for the National Multiple Sclerosis Society and Congressionally Directed Medical Research Programs, Multiple Sclerosis Research Program for the Department of Defense.

Ethan G. Hughes is an Assistant Professor in the Cell and Developmental Biology Department at the University of Colorado School of Medicine. He leads a laboratory focused on understanding how neuron-glial interactions modulate brain function and contribute to pathology in neurodegenerative disease. Dr. Hughes obtained his B.S. degree in Biology with Special Honors from George Washington University (2003) and his Ph.D. in the laboratory of Rita Balice-Gordon at the University of Pennsylvania (2009) studying the mechanisms of synapse formation and maintenance. As a postdoctoral fellow under the mentorship of Dwight Bergles at Johns Hopkins University, Dr. Hughes examined cellular dynamics of oligodendrocyte lineage cells and myelination in the adult brain using longitudinal in vivo two-photon microscopy. In 2016, Dr. Hughes joined the faculty at the University of Colorado School of Medicine. He is an awardee of the Whitehall Foundation Fellowship, Marilyn Hilton Award for Innovation in MS Research, Webb-Waring Biomedical Research Award, and a ACTRIMS Young Investigator Award. He serves on study sections for the National Multiple Sclerosis Society and Congressionally Directed Medical Research Programs, Multiple Sclerosis Research Program for the Department of Defense.

Gerd Kempermann, born in 1965, studied Medicine in Cologne and Freiburg, Germany. From 1995 to 1998 he was postdoctoral fellow with Fred H. Gage at the Salk Institute and between 2000 and 2007 group leader at the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch. In 2007 he became Professor at the CRTD – Center for Regenerative Therapies at TU Dresden. Since 2009 he leads the Dresden site of the German Center for Neurodegenerative Disease (DZNE). Main topics of his work are the function and activity-dependent regulation of adult hippocampal neurogenesis, the neurobiology of individuality and the biological foundations of healthy cognitive aging.

Gerd Kempermann, born in 1965, studied Medicine in Cologne and Freiburg, Germany. From 1995 to 1998 he was postdoctoral fellow with Fred H. Gage at the Salk Institute and between 2000 and 2007 group leader at the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch. In 2007 he became Professor at the CRTD – Center for Regenerative Therapies at TU Dresden. Since 2009 he leads the Dresden site of the German Center for Neurodegenerative Disease (DZNE). Main topics of his work are the function and activity-dependent regulation of adult hippocampal neurogenesis, the neurobiology of individuality and the biological foundations of healthy cognitive aging.

Daan Kenis is currently working as a PhD researcher at the Centre for Ethics at the University of Antwerp. He is involved in the NeuroEpigenEthics groups which explores the complex entanglements between human biology and philosophy using both theoretical and empirical methods. His current work is on the ethics of Precision Medicine. He approaches this novel data-driven medical paradigm from a feminist standpoint epistemological approach. As such, he is exploring the social and ethical repercussions of the central epistemological commitments of Precision Medicine and their impact on clinical care. Prior to getting his Master’s in Philosophy, he studied pharmaceutical sciences and drug development at the University of Ghent. After which he worked as a Community Pharmacist for several years. His research interests include: Philosophy of Medicine, Philosophy of Systems Biology, Philosophy of Science and Feminist Philosophy.

Daan Kenis is currently working as a PhD researcher at the Centre for Ethics at the University of Antwerp. He is involved in the NeuroEpigenEthics groups which explores the complex entanglements between human biology and philosophy using both theoretical and empirical methods. His current work is on the ethics of Precision Medicine. He approaches this novel data-driven medical paradigm from a feminist standpoint epistemological approach. As such, he is exploring the social and ethical repercussions of the central epistemological commitments of Precision Medicine and their impact on clinical care. Prior to getting his Master’s in Philosophy, he studied pharmaceutical sciences and drug development at the University of Ghent. After which he worked as a Community Pharmacist for several years. His research interests include: Philosophy of Medicine, Philosophy of Systems Biology, Philosophy of Science and Feminist Philosophy.

Tatiana Korotkova studied biology with a focus on human and animal physiology in Lomonosov Moscow State University. During her Ph.D. under the supervision of Dr. R.E. Brown and Prof. H.L. Haas in Düsseldorf she investigated actions of various hypothalamic neuropeptides on aminergic nuclei, particularly on dopaminergic system. As a postdoc in the lab of Prof H. Monyer in Heidelberg, and later in a collaboration with Prof. T. J. Jentsch in Berlin she studied mechanisms of hippocampal network oscillations in behaving transgenic mice. In 2012-2017 T. Korotkova was a junior group leader at the Leibniz Institute of Molecular Pharmacology (FMP)/Neurocure Cluster of Excellence in Berlin, in 2017-2019 - a research group leader at MPI for Metabolism Research. Since 2019 T.Korotkova is a Full Professor and Managing Director at the Institute of Physiology, University of Cologne. She was a holder of the DFG and Schering foundation research stipends, and was awarded the Human Frontier Science Program (HFSP) Grant as well as the Junior Brain Prize by Lundbeck Foundation. The group of Tatiana Korotkova investigates neuronal mechanisms of innate behaviors, including feeding, social interactions and voluntary locomotion, in health and disease. Her research is supported by the European Research Council and by the German Research Organization (DFG). She supervised 10 Ph.D. and 12 M.Sc. students, and co-authored 29 peer-reviewed original publications, 3 reviews as well as one book chapter.

Tatiana Korotkova studied biology with a focus on human and animal physiology in Lomonosov Moscow State University. During her Ph.D. under the supervision of Dr. R.E. Brown and Prof. H.L. Haas in Düsseldorf she investigated actions of various hypothalamic neuropeptides on aminergic nuclei, particularly on dopaminergic system. As a postdoc in the lab of Prof H. Monyer in Heidelberg, and later in a collaboration with Prof. T. J. Jentsch in Berlin she studied mechanisms of hippocampal network oscillations in behaving transgenic mice. In 2012-2017 T. Korotkova was a junior group leader at the Leibniz Institute of Molecular Pharmacology (FMP)/Neurocure Cluster of Excellence in Berlin, in 2017-2019 - a research group leader at MPI for Metabolism Research. Since 2019 T.Korotkova is a Full Professor and Managing Director at the Institute of Physiology, University of Cologne. She was a holder of the DFG and Schering foundation research stipends, and was awarded the Human Frontier Science Program (HFSP) Grant as well as the Junior Brain Prize by Lundbeck Foundation. The group of Tatiana Korotkova investigates neuronal mechanisms of innate behaviors, including feeding, social interactions and voluntary locomotion, in health and disease. Her research is supported by the European Research Council and by the German Research Organization (DFG). She supervised 10 Ph.D. and 12 M.Sc. students, and co-authored 29 peer-reviewed original publications, 3 reviews as well as one book chapter.

Corentin Le Magueresse is a neurophysiologist at the Institut du Fer à Moulin, a joint Unit of INSERM and Sorbonne University in Paris. He studied chemical engineering in Montpellier and Glasgow before obtaining an M.Sc. in neuropharmacology in Paris. During his PhD under the supervision of Jean-Pierre Changeux in Paris and Enrico Cherubini in Trieste, he investigated the role of nicotinic acetylcholine receptors in synaptic and network activity in the immature rodent hippocampus. As a postdoctoral scientist in the lab of Hannah Monyer in Heidelberg, he studied the postnatal neurogenesis of GABAergic interneurons in the neonatal brain. Since 2013 Corentin Le Magueresse is a tenured P.I. at INSERM, where his research focuses on immune-brain interactions during postnatal maturation and on the etiology of neurodevelopmental disorders. Recently, he and his group have shown that overexpression of an immune genetic risk factor for schizophrenia in the mouse brain recapitulates several cellular phenotypes of the disease, shedding light on the relationship between immunity and distinct hypotheses of schizophrenia. He has been the recipient of a Marie Curie Career Integration Grant and of two Emergence Grants from Sorbonne University. His research is currently supported by INSERM, the Fondation de France and the ERANET-Neuron program.

Corentin Le Magueresse is a neurophysiologist at the Institut du Fer à Moulin, a joint Unit of INSERM and Sorbonne University in Paris. He studied chemical engineering in Montpellier and Glasgow before obtaining an M.Sc. in neuropharmacology in Paris. During his PhD under the supervision of Jean-Pierre Changeux in Paris and Enrico Cherubini in Trieste, he investigated the role of nicotinic acetylcholine receptors in synaptic and network activity in the immature rodent hippocampus. As a postdoctoral scientist in the lab of Hannah Monyer in Heidelberg, he studied the postnatal neurogenesis of GABAergic interneurons in the neonatal brain. Since 2013 Corentin Le Magueresse is a tenured P.I. at INSERM, where his research focuses on immune-brain interactions during postnatal maturation and on the etiology of neurodevelopmental disorders. Recently, he and his group have shown that overexpression of an immune genetic risk factor for schizophrenia in the mouse brain recapitulates several cellular phenotypes of the disease, shedding light on the relationship between immunity and distinct hypotheses of schizophrenia. He has been the recipient of a Marie Curie Career Integration Grant and of two Emergence Grants from Sorbonne University. His research is currently supported by INSERM, the Fondation de France and the ERANET-Neuron program.

Prof Tarja Malm is Professor (tenure track) in Molecular Neurobiology and the head of the Neuroinflammation research group at the A.I.Virtanen Institute, University of Eastern Finland. She obtained her PhD in 2006 in Neurobiology with the focus glial cell biology and carried out her postdoctoral training at the Case Western Reserve University, USA.
Her research focuses on understanding how and why microglia become malfunctional in different neurodegenerative diseases and how environmental factors, such as infections and air pollution alter microglial functionality and microglia-neuron interactions. Her group uses interdisciplinary approaches and develops novel, human based models to find therapeutic strategies to combat brain diseases. Her research group has pioneered development of methodologies to differentiate microglia and microglia containing cerebral organoids from human induced pluripotent stem cells. These models enable investigation of air pollution effects on microglia functionality and microglia-neuron interaction.

Prof Tarja Malm is Professor (tenure track) in Molecular Neurobiology and the head of the Neuroinflammation research group at the A.I.Virtanen Institute, University of Eastern Finland. She obtained her PhD in 2006 in Neurobiology with the focus glial cell biology and carried out her postdoctoral training at the Case Western Reserve University, USA.
Her research focuses on understanding how and why microglia become malfunctional in different neurodegenerative diseases and how environmental factors, such as infections and air pollution alter microglial functionality and microglia-neuron interactions. Her group uses interdisciplinary approaches and develops novel, human based models to find therapeutic strategies to combat brain diseases. Her research group has pioneered development of methodologies to differentiate microglia and microglia containing cerebral organoids from human induced pluripotent stem cells. These models enable investigation of air pollution effects on microglia functionality and microglia-neuron interaction.

Yvonne Nolan is a Professor in Anatomy and Neuroscience, Funded Investigator in APC Microbiome Ireland and Vice Dean of Graduate Studies in the College of Medicine and Health at University College Cork. Yvonne graduated from NUI, Galway with a BSc (Hons) in Biochemistry, and a PhD in Neuropharmacology. She was a visiting scholar at McGill University Montreal, Canada and held postdoctoral positions in Trinity College, Dublin before her appointment to the Department of Anatomy and Neuroscience, University College Cork.
Research in Professor Nolan’s team investigates the impact of inflammation and modifiable lifestyle factors such as exercise, stress and diet on memory and mood though the lifespan. The role of the gut microbiome and hippocampal neurogenesis is of particular interest. To date she has supervised >30 PhD/MSc (research)/postdoctoral researchers as well as numerous visiting and undergraduate students. She was awarded UCC’s Research Supervisor of the Year Award in 2016. She has several international collaborations with academic and industrial partners, is actively involved in mentoring and public engagement activities, and her team have had recognition for research in the form of prizes, and image exhibitions. She has secured ~€6M in funding from Science Foundation Ireland, Reta Lila Weston Trust, Marigot Ltd, Irish Research Council and Vasogen Inc., Canada. She was consortium lead on a recent European Centres of Excellence in Neurodegeneration (COEN) project.

Yvonne Nolan is a Professor in Anatomy and Neuroscience, Funded Investigator in APC Microbiome Ireland and Vice Dean of Graduate Studies in the College of Medicine and Health at University College Cork. Yvonne graduated from NUI, Galway with a BSc (Hons) in Biochemistry, and a PhD in Neuropharmacology. She was a visiting scholar at McGill University Montreal, Canada and held postdoctoral positions in Trinity College, Dublin before her appointment to the Department of Anatomy and Neuroscience, University College Cork.
Research in Professor Nolan’s team investigates the impact of inflammation and modifiable lifestyle factors such as exercise, stress and diet on memory and mood though the lifespan. The role of the gut microbiome and hippocampal neurogenesis is of particular interest. To date she has supervised >30 PhD/MSc (research)/postdoctoral researchers as well as numerous visiting and undergraduate students. She was awarded UCC’s Research Supervisor of the Year Award in 2016. She has several international collaborations with academic and industrial partners, is actively involved in mentoring and public engagement activities, and her team have had recognition for research in the form of prizes, and image exhibitions. She has secured ~€6M in funding from Science Foundation Ireland, Reta Lila Weston Trust, Marigot Ltd, Irish Research Council and Vasogen Inc., Canada. She was consortium lead on a recent European Centres of Excellence in Neurodegeneration (COEN) project.

Valentina Parma, PhD is a psychologist interested in human olfaction across the lifespan. She received her BS and MSc in Experimental Psychology and Cognitive Neuroscience from the University of Padova, Italy. After her PhD in Experimental Psychology at the University of Padova, Italy, she completed postdoctoral work at the Monell Chemical Senses Center in Philadelphia, PA, USA and at the International School for Advanced Studies in Trieste, Italy. After becoming Research Assistant Professor at Temple University in Philadelphia, PA, USA, she is now the Assistant Director and Assistant Member (Professor) of the Monell Chemical Senses Center. Both her basic and translational work aim at finding ways to use smell as an opportunity to improve health. She primarily uses behavioral and psychophysiological methods to understand how odors influence typical and atypical behavior. Recently, she has chaired the Global Consortium for Chemosensory Research (GCCR) a worldwide effort to understand how smell, taste and chemesthesis are affected by COVID-19 and other respiratory disorders. She has co-developed smell tests to facilitate awareness of chemosensory loss and distortion, and she is working to bring new solutions to improve chemosensory recovery.

Valentina Parma, PhD is a psychologist interested in human olfaction across the lifespan. She received her BS and MSc in Experimental Psychology and Cognitive Neuroscience from the University of Padova, Italy. After her PhD in Experimental Psychology at the University of Padova, Italy, she completed postdoctoral work at the Monell Chemical Senses Center in Philadelphia, PA, USA and at the International School for Advanced Studies in Trieste, Italy. After becoming Research Assistant Professor at Temple University in Philadelphia, PA, USA, she is now the Assistant Director and Assistant Member (Professor) of the Monell Chemical Senses Center. Both her basic and translational work aim at finding ways to use smell as an opportunity to improve health. She primarily uses behavioral and psychophysiological methods to understand how odors influence typical and atypical behavior. Recently, she has chaired the Global Consortium for Chemosensory Research (GCCR) a worldwide effort to understand how smell, taste and chemesthesis are affected by COVID-19 and other respiratory disorders. She has co-developed smell tests to facilitate awareness of chemosensory loss and distortion, and she is working to bring new solutions to improve chemosensory recovery.

Dr. Natale Sciolino completed her PhD in Neuroscience at the University of Georgia under the direction of two leading noradrenergic neurobiologists, Philip V. Holmes, PhD (UGA) and David Weinshenker, PhD (Emory) using in vivo microdialysis and behavior to study the noradrenergic-galanin system in anxiety and addiction. She then went on to complete a postdoctoral fellowship with Patricia Jensen, PhD at the NIH, where she used the latest advances in intersectional genetics, optical imaging, and electrophysiology to uncover a role for locus coeruleus (LC) norepinephrine neurons in regulating anxiety and feeding. Natale received an NIH K99/R00 Pathway to Independence Award from NIDDK and joined the Department of Physiology & Neurobiology at UCONN in 2021. The focus of her research program is to define the connectivity and function of hindbrain norepinephrine (NE) circuits that regulate motivational processes related to feeding, reward, and emotion. Her lab takes a multidisciplinary approach to study the neurobiology of motivation using tools spanning genetic, molecular, cellular, & systems neuroscience.

Dr. Natale Sciolino completed her PhD in Neuroscience at the University of Georgia under the direction of two leading noradrenergic neurobiologists, Philip V. Holmes, PhD (UGA) and David Weinshenker, PhD (Emory) using in vivo microdialysis and behavior to study the noradrenergic-galanin system in anxiety and addiction. She then went on to complete a postdoctoral fellowship with Patricia Jensen, PhD at the NIH, where she used the latest advances in intersectional genetics, optical imaging, and electrophysiology to uncover a role for locus coeruleus (LC) norepinephrine neurons in regulating anxiety and feeding. Natale received an NIH K99/R00 Pathway to Independence Award from NIDDK and joined the Department of Physiology & Neurobiology at UCONN in 2021. The focus of her research program is to define the connectivity and function of hindbrain norepinephrine (NE) circuits that regulate motivational processes related to feeding, reward, and emotion. Her lab takes a multidisciplinary approach to study the neurobiology of motivation using tools spanning genetic, molecular, cellular, & systems neuroscience.

Dr. Kate Smith is an Assistant Professor at the University of Colorado, where she studies the molecular mechanisms that control inhibitory synaptic plasticity and how they goes awry in brain disorders. Kate was awarded an M.Sci degree in Biochemistry from Imperial College, London in 2005, and received her Ph.D. in molecular neuroscience from University College London in 2010. In 2012, Kate was awarded a Marie Curie Outgoing Post-doctoral Fellowship to conduct research under the mentorship of Dr. Peter Penzes (Northwestern University, Chicago) and Dr. Jonathan Hanley (University of Bristol, UK), where she leveraged emerging super-resolution imaging techniques to study the details of synapses during plasticity. After moving back and forth across the Atlantic, she decided to begin her independent career in the US, at the University of Colorado School of Medicine Department of Pharmacology. Kate has received an NARSAD Young Investigator Award, an American Heart Association Career Development Award and Brain Research Foundation Award.

Dr. Kate Smith is an Assistant Professor at the University of Colorado, where she studies the molecular mechanisms that control inhibitory synaptic plasticity and how they goes awry in brain disorders. Kate was awarded an M.Sci degree in Biochemistry from Imperial College, London in 2005, and received her Ph.D. in molecular neuroscience from University College London in 2010. In 2012, Kate was awarded a Marie Curie Outgoing Post-doctoral Fellowship to conduct research under the mentorship of Dr. Peter Penzes (Northwestern University, Chicago) and Dr. Jonathan Hanley (University of Bristol, UK), where she leveraged emerging super-resolution imaging techniques to study the details of synapses during plasticity. After moving back and forth across the Atlantic, she decided to begin her independent career in the US, at the University of Colorado School of Medicine Department of Pharmacology. Kate has received an NARSAD Young Investigator Award, an American Heart Association Career Development Award and Brain Research Foundation Award.

Henning Sprekeler studied physics in Freiburg and Berlin before obtaining a PhD in biology from the Humboldt-Universität zu Berlin in 2008. After two postdocs at EPFL in Lausanne and HU Berlin, he received the Bernstein Award from the German Ministry for Science and Education, which allowed him to start his own research group at HU Berlin in 2012. In 2013, he moved to the University of Cambridge (UK) as a lecturer in the Department of Engineering, before taking up his current position as a full professor for computer science at Technische Universität Berlin in 2014. He is a member of the Bernstein Center for Computational Neuroscience Berlin and the Cluster of Excellence “Science of Intelligence”.  His research uses computational and machine learning approaches to study neural circuits, learning and memory. 

Henning Sprekeler studied physics in Freiburg and Berlin before obtaining a PhD in biology from the Humboldt-Universität zu Berlin in 2008. After two postdocs at EPFL in Lausanne and HU Berlin, he received the Bernstein Award from the German Ministry for Science and Education, which allowed him to start his own research group at HU Berlin in 2012. In 2013, he moved to the University of Cambridge (UK) as a lecturer in the Department of Engineering, before taking up his current position as a full professor for computer science at Technische Universität Berlin in 2014. He is a member of the Bernstein Center for Computational Neuroscience Berlin and the Cluster of Excellence “Science of Intelligence”.  His research uses computational and machine learning approaches to study neural circuits, learning and memory. 

Gina Turrigiano received her BA from Reed College in 1984 and her PhD from UC San Diego in 1990. She trained as a postdoc with Eve Marder at Brandeis University before joining the Brandeis faculty in 1994, where she is now the Levitan Professor of Vision Science in the Department of Biology. Her work has focused on identifying the cellular and circuit mechanisms that stabilize neural circuit function, especially the discovery and characterization of homeostatic forms of synaptic and intrinsic plasticity. She has received numerous awards for this research, including a MacArthur fellowship, an NIH director’s pioneer award, and the HFSP Nakasone Award. She is a fellow of AAAS and a member of the American Academy of Arts and Sciences and the National Academy of Sciences. She is currently the President of the Society for Neuroscience.

Gina Turrigiano received her BA from Reed College in 1984 and her PhD from UC San Diego in 1990. She trained as a postdoc with Eve Marder at Brandeis University before joining the Brandeis faculty in 1994, where she is now the Levitan Professor of Vision Science in the Department of Biology. Her work has focused on identifying the cellular and circuit mechanisms that stabilize neural circuit function, especially the discovery and characterization of homeostatic forms of synaptic and intrinsic plasticity. She has received numerous awards for this research, including a MacArthur fellowship, an NIH director’s pioneer award, and the HFSP Nakasone Award. She is a fellow of AAAS and a member of the American Academy of Arts and Sciences and the National Academy of Sciences. She is currently the President of the Society for Neuroscience.

Dr. Susanne van Veluw is an Assistant Professor in the department of Neurology at Massachusetts General Hospital (MGH) / Harvard Medical School, in Boston, USA. She obtained her MSc in clinical neuroscience at the Free University in Amsterdam, and her PhD at the University Medical Center in Utrecht, the Netherlands. During her PhD in the group of Dr. Geert Jan Biessels, she used high field 7 tesla MRI and neuropathological examination in brain tissue of older individuals to study the impact of microvascular pathology on brain structure and cognitive function. For her post-doctoral training, she moved to Boston to work with Drs. Steven Greenberg and Brian Bacskai at MGH on microvascular pathology in patients with cerebral amyloid angiopathy (CAA). In March 2020, she joined the Neurology faculty at MGH as an Assistant Professor, and she is affiliated with the Leiden University Medical Center, in the Netherlands. Her lab uses translational imaging approaches, ranging from ex vivo MRI-guided histopathology in human brain tissue to in vivo two-photon microscopy in mice to better understand the pathophysiology of sporadic and hereditary CAA. In particular, the Van Veluw lab is interested in unraveling the mechanisms of hemorrhage formation in CAA and studying the driving force of perivascular β-amyloid clearance, with the goal to find novel targets for therapeutic intervention aimed at preventing hemorrhagic stroke and cognitive impairment in patients with small vessel disease.

Dr. Susanne van Veluw is an Assistant Professor in the department of Neurology at Massachusetts General Hospital (MGH) / Harvard Medical School, in Boston, USA. She obtained her MSc in clinical neuroscience at the Free University in Amsterdam, and her PhD at the University Medical Center in Utrecht, the Netherlands. During her PhD in the group of Dr. Geert Jan Biessels, she used high field 7 tesla MRI and neuropathological examination in brain tissue of older individuals to study the impact of microvascular pathology on brain structure and cognitive function. For her post-doctoral training, she moved to Boston to work with Drs. Steven Greenberg and Brian Bacskai at MGH on microvascular pathology in patients with cerebral amyloid angiopathy (CAA). In March 2020, she joined the Neurology faculty at MGH as an Assistant Professor, and she is affiliated with the Leiden University Medical Center, in the Netherlands. Her lab uses translational imaging approaches, ranging from ex vivo MRI-guided histopathology in human brain tissue to in vivo two-photon microscopy in mice to better understand the pathophysiology of sporadic and hereditary CAA. In particular, the Van Veluw lab is interested in unraveling the mechanisms of hemorrhage formation in CAA and studying the driving force of perivascular β-amyloid clearance, with the goal to find novel targets for therapeutic intervention aimed at preventing hemorrhagic stroke and cognitive impairment in patients with small vessel disease.

Valentin Wyart is a research scientist at the Cognitive Computational Neuroscience Lab of the Ecole Normale Supérieure in Paris, France. His research group studies human learning and decision-making under uncertainty, with a particular focus on the sources of cognitive variability both within and between individuals. The research carried out in his group typically combines behavioral modeling with multimodal functional neuroimaging.
He was originally trained in mathematics and computer science. He obtained a Master degree in cognitive science, and completed his PhD at Sorbonne Université in 2009 under the supervision of Catherine Tallon-Baudry and Stanislas Dehaene. His thesis examined the relation between the neural correlates of visual consciousness and spatial attention. He then moved to Oxford to work with Chris Summerfield and Kia Nobre on the relation between brain oscillations and perceptual decisions. He moved back to Paris in 2012 to join the Cognitive Computational Neuroscience Lab of the Ecole Normale Supérieure as a research fellow, before starting his own research group in 2017 with support from the Institut National de la Santé et de la Recherche Médicale (Inserm) and the European Research Council (ERC).

Valentin Wyart is a research scientist at the Cognitive Computational Neuroscience Lab of the Ecole Normale Supérieure in Paris, France. His research group studies human learning and decision-making under uncertainty, with a particular focus on the sources of cognitive variability both within and between individuals. The research carried out in his group typically combines behavioral modeling with multimodal functional neuroimaging.
He was originally trained in mathematics and computer science. He obtained a Master degree in cognitive science, and completed his PhD at Sorbonne Université in 2009 under the supervision of Catherine Tallon-Baudry and Stanislas Dehaene. His thesis examined the relation between the neural correlates of visual consciousness and spatial attention. He then moved to Oxford to work with Chris Summerfield and Kia Nobre on the relation between brain oscillations and perceptual decisions. He moved back to Paris in 2012 to join the Cognitive Computational Neuroscience Lab of the Ecole Normale Supérieure as a research fellow, before starting his own research group in 2017 with support from the Institut National de la Santé et de la Recherche Médicale (Inserm) and the European Research Council (ERC).